164 related articles for article (PubMed ID: 25176518)
1. [Risk factors for cancer in patients with myositis. Clinical, immunological characteristics and the role of the anti-p155/140 antibody].
Szankai Z; Nagy-Vincze M; Bodoki L; Jakab A; Betteridge Z; Dankó K
Orv Hetil; 2014 Sep; 155(36):1437-44. PubMed ID: 25176518
[TBL] [Abstract][Full Text] [Related]
2. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
3. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
Váncsa A; Dankó K
Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
[TBL] [Abstract][Full Text] [Related]
4. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
6. [Malignancy-associated myositis].
Shimizu J
Brain Nerve; 2010 Apr; 62(4):427-32. PubMed ID: 20420184
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated myositis: clinical features and prognostic signs.
Ponyi A; Constantin T; Garami M; András C; Tállai B; Váncsa A; Gergely L; Dankó K
Ann N Y Acad Sci; 2005 Jun; 1051():64-71. PubMed ID: 16126945
[TBL] [Abstract][Full Text] [Related]
8. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.
Tiniakou E; Mammen AL
Clin Rev Allergy Immunol; 2017 Feb; 52(1):20-33. PubMed ID: 26429706
[TBL] [Abstract][Full Text] [Related]
10. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
Mimori T; Imura Y; Nakashima R; Yoshifuji H
Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
[TBL] [Abstract][Full Text] [Related]
12. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
Allenbach Y; Keraen J; Bouvier AM; Jooste V; Champtiaux N; Hervier B; Schoindre Y; Rigolet A; Gilardin L; Musset L; Charuel JL; Boyer O; Jouen F; Drouot L; Martinet J; Stojkovic T; Eymard B; Laforêt P; Behin A; Salort-Campana E; Fain O; Meyer A; Schleinitz N; Mariampillai K; Grados A; Benveniste O
Brain; 2016 Aug; 139(Pt 8):2131-5. PubMed ID: 27086869
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibody profile in myositis].
Allenbach Y; Benveniste O
Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
[TBL] [Abstract][Full Text] [Related]
14. Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Jobanputra R; Dankó K
Acta Reumatol Port; 2015; 40(4):337-47. PubMed ID: 26922197
[TBL] [Abstract][Full Text] [Related]
15. Immunoserological aspects of idiopathic inflammatory muscle disease.
Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T
Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964
[TBL] [Abstract][Full Text] [Related]
16. [Myositis-specific autoantibodies and their clinical significance].
Suzuki S
Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
Bodoki L; Budai D; Nagy-Vincze M; Griger Z; Betteridge Z; Dankó K
Orv Hetil; 2015 Sep; 156(36):1451-9. PubMed ID: 26320599
[TBL] [Abstract][Full Text] [Related]
18. [New autoantibodies in dermatomyositis].
Bielsa I
Actas Dermosifiliogr; 2009 Apr; 100(3):182-9. PubMed ID: 19457303
[TBL] [Abstract][Full Text] [Related]
19. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.
András C; Ponyi A; Constantin T; Csiki Z; Szekanecz E; Szodoray P; Dankó K
J Rheumatol; 2008 Mar; 35(3):438-44. PubMed ID: 18203322
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Features of Myositis-Associated Autoantibodies: a Review.
Gunawardena H
Clin Rev Allergy Immunol; 2017 Feb; 52(1):45-57. PubMed ID: 26453338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
